中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
16期
2512-2518
,共7页
陈林%严华%陈丽媛%陆永光%符春晖%郑战传
陳林%嚴華%陳麗媛%陸永光%符春暉%鄭戰傳
진림%엄화%진려원%륙영광%부춘휘%정전전
生物材料%材料相容性%封堵器%先天性心脏病%房间隔缺损%室间隔缺损%动脉导管未闭%血小板活化%凝血敏感蛋白
生物材料%材料相容性%封堵器%先天性心髒病%房間隔缺損%室間隔缺損%動脈導管未閉%血小闆活化%凝血敏感蛋白
생물재료%재료상용성%봉도기%선천성심장병%방간격결손%실간격결손%동맥도관미폐%혈소판활화%응혈민감단백
septal occluder device%heart diseases%platelet activation%thrombospondins
背景:封堵器植入先天性心脏病患者体内后会增加血小板的黏附聚集,造成封堵器表面血栓形成。目的:探讨先天性心脏病封堵术后封堵器对患者血小板功能的影响。方法:回顾性分析124例先天性心脏病封堵患者的临床资料,其中房间隔缺损组46例、动脉导管未闭组43例及室间隔缺损组35例,均采用封堵器封堵。封堵前、封堵后6 h、封堵后24 h、封堵后12个月对比3组外周血中CD 62p、CD 63结果与结论:封堵前3组外周血中CD和凝血酶敏感蛋白的阳性表达率。62p、CD 63和凝血酶敏感蛋白阳性表达率差异无显著性意义。3组外周血中CD62p、CD63和凝血酶敏感蛋白水平均于封堵后6 h达到最高值,尤以房间隔缺损组及室间隔缺损组升高显著,之后逐渐下降;至12个月时,动脉导管未闭组、室间隔缺损组CD 62p、CD 63水平恢复至封堵前水平,而房间隔缺损组CD 62p、CD 63水平仍保持在较高水平,并且明显高于动脉导管未闭组、室间隔缺损组(P <0.05);3组间不同时间点凝血酶敏感蛋白水平比较差异无显著性意义。表明封堵器植入后,先天性房间隔缺损与室间隔缺损患者血小板功能活化明显,尤以房间隔缺损更甚,持续时间更长。
揹景:封堵器植入先天性心髒病患者體內後會增加血小闆的黏附聚集,造成封堵器錶麵血栓形成。目的:探討先天性心髒病封堵術後封堵器對患者血小闆功能的影響。方法:迴顧性分析124例先天性心髒病封堵患者的臨床資料,其中房間隔缺損組46例、動脈導管未閉組43例及室間隔缺損組35例,均採用封堵器封堵。封堵前、封堵後6 h、封堵後24 h、封堵後12箇月對比3組外週血中CD 62p、CD 63結果與結論:封堵前3組外週血中CD和凝血酶敏感蛋白的暘性錶達率。62p、CD 63和凝血酶敏感蛋白暘性錶達率差異無顯著性意義。3組外週血中CD62p、CD63和凝血酶敏感蛋白水平均于封堵後6 h達到最高值,尤以房間隔缺損組及室間隔缺損組升高顯著,之後逐漸下降;至12箇月時,動脈導管未閉組、室間隔缺損組CD 62p、CD 63水平恢複至封堵前水平,而房間隔缺損組CD 62p、CD 63水平仍保持在較高水平,併且明顯高于動脈導管未閉組、室間隔缺損組(P <0.05);3組間不同時間點凝血酶敏感蛋白水平比較差異無顯著性意義。錶明封堵器植入後,先天性房間隔缺損與室間隔缺損患者血小闆功能活化明顯,尤以房間隔缺損更甚,持續時間更長。
배경:봉도기식입선천성심장병환자체내후회증가혈소판적점부취집,조성봉도기표면혈전형성。목적:탐토선천성심장병봉도술후봉도기대환자혈소판공능적영향。방법:회고성분석124례선천성심장병봉도환자적림상자료,기중방간격결손조46례、동맥도관미폐조43례급실간격결손조35례,균채용봉도기봉도。봉도전、봉도후6 h、봉도후24 h、봉도후12개월대비3조외주혈중CD 62p、CD 63결과여결론:봉도전3조외주혈중CD화응혈매민감단백적양성표체솔。62p、CD 63화응혈매민감단백양성표체솔차이무현저성의의。3조외주혈중CD62p、CD63화응혈매민감단백수평균우봉도후6 h체도최고치,우이방간격결손조급실간격결손조승고현저,지후축점하강;지12개월시,동맥도관미폐조、실간격결손조CD 62p、CD 63수평회복지봉도전수평,이방간격결손조CD 62p、CD 63수평잉보지재교고수평,병차명현고우동맥도관미폐조、실간격결손조(P <0.05);3조간불동시간점응혈매민감단백수평비교차이무현저성의의。표명봉도기식입후,선천성방간격결손여실간격결손환자혈소판공능활화명현,우이방간격결손경심,지속시간경장。
BACKGROUND:Occluder implantation in patients with congenital heart disease can increase in vivo platelet adhesion and aggregation, resulting in thrombosis on the occluder surface. OBJECTIVE:To investigate the effect of the occluder on platelet function in patients with congenital heart disease undergoing transcatheter closure. METHODS: Clinical data from 124 patients with congenital heart disease undergoing transcatheter closure were retrospectively analyzed. These patients were divided into groups of atrial septal defect in 46 cases, patent ductus arteriosus in 43 cases and ventricular septal defect in 35 cases according to the types of congenital heart disease. The positive rates for peripheral blood CD62p, CD63 RESULTS AND CONCLUSION:There was no difference in the positive rates of peripheral blood CD and thrombin sensitive protein were compared before and 6 hours, 24 hours, 12 months after occluder implantation. 62p, CD63 and thrombin sensitive protein among three groups prior to occluder implantation. Up to 6 hours after occluder implantation, the expression levels of peripheral blood CD62p, CD63 and thrombin sensitive protein reached peak in the three groups, especialy in the patients with atrial septal defect and ventricular septal defect, then gradualy decreased. After 12 months, the expression levels of CD62p and CD63 recovered in the patients with patent ductus arteriosus and ventricular septal defect, but stil maintained a higher level in those with atrial septal defect (P < 0.05). The expression of thrombin sensitive protein showed no difference among the three groups at different time. These findings indicate that after occluder implantation, the platelet activation is more remarkable and lasts longer in the patients with atrial septal defect and ventricular septal defect, especialy in those with ventricular septal defect.